United Therapeutics Corp. (UTHR) News Nov 20, 2014
Post# of 250662
Posted On: 11/21/2014 1:48:21 AM
United Therapeutics Corp. (UTHR) News Nov 20, 2014, 5:33 p.m.
MarketWatch News on UTHR
Despite bullish backdrop, technical tests are in play 11:26 a.m. Sept. 9, 2014 - Michael Ashbaugh
Despite bullish backdrop, technical tests are in play 11:07 a.m. Sept. 9, 2014 - Michael Ashbaugh
Charting the technical (and bullish) cross currents 12:51 p.m. Feb. 21, 2014 - Michael Ashbaugh
CalAmp drops, ImmunoCellular rises after hours 6:07 p.m. Dec. 23, 2013 - Wallace Witkowski
Sell in November? No 10:52 a.m. Oct. 31, 2013 - Michael Ashbaugh
Charting the Nasdaq’s 12-year breakout 11:56 a.m. April 30, 2013 - Michael Ashbaugh
Charting the Nasdaq’s 12-year breakout 11:34 a.m. April 30, 2013 - Michael Ashbaugh
United Therapeutics: FDA again rejects drug 6:56 a.m. March 25, 2013 - MarketWatch.com
Look for bargains in health care, tech, energy, housing and airlines: Sabrient's Brown 4:46 p.m. Nov. 21, 2012 - blogs.marketwatch.com
Wednesday’s biggest movers: Facebook, Yelp rally 6:29 p.m. Oct. 24, 2012 - Sue Chang
FDA declines to OK United Therapeutics product 6:53 a.m. Oct. 24, 2012 - MarketWatch.com
Charting the longer-term market backdrop 11:30 a.m. Sept. 25, 2012 - Michael Ashbaugh
Charting the longer-term market backdrop 10:53 a.m. Sept. 25, 2012 - Michael Ashbaugh
S&P, Nasdaq retest major support 10:09 a.m. July 11, 2012 - Michael Ashbaugh
6 charts for the week 12:54 p.m. June 25, 2012 - The Trading Deck
13 stocks for 2012 5:57 p.m. Jan. 5, 2012 - blogs.marketwatch.com
Wednesday’s biggest gaining and declining stocks 3:29 p.m. Aug. 24, 2011 - Kate Gibson
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:50 p.m. June 6, 2011 - Kate Gibson
Utd Therapeutics hypertension drug hits trial goal 11:32 a.m. June 6, 2011 - MarketWatch.com
Other News on UTHR
The 3 Best ETFs for Mid-Cap Growth 5:50 a.m. Nov. 17, 2014 - InvestorPlace.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog 12:02 p.m. Oct. 29, 2014 - Zacks.com
United Therapeutics' (UTHR) CEO Martine Rothblatt on Q3 2014 Results - Earnings Call Transcript 6:10 p.m. Oct. 28, 2014 - Seeking Alpha
United Therapeutics ups revenues 9% in Q3 10:53 a.m. Oct. 28, 2014 - Seeking Alpha
Worst Performing Industries For October 28, 2014 10:13 a.m. Oct. 28, 2014 - benzinga.com
Weak On High Volume: United Therapeutics (UTHR) 10:04 a.m. Oct. 28, 2014 - TheStreet.com
United Therapeutics (UTHR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Oct. 28, 2014 - Seeking Alpha
10-Q: UNITED THERAPEUTICS CORP 6:06 a.m. Oct. 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
United Therapeutics Corporation (UTHR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 27, 2014 - Zacks.com
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 8:21 a.m. Oct. 24, 2014 - Seeking Alpha
Biotechs Show Fed Chief's Not Much Of A Stock Analyst 4:01 p.m. Oct. 22, 2014 - Investors Business Daily
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog 5:30 p.m. Oct. 14, 2014 - Zacks.com
J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog 11:27 a.m. Oct. 14, 2014 - Zacks.com
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. 10:58 a.m. Oct. 12, 2014 - GuruFocus.com
A Look At Arena's Other Drug 4:37 p.m. Oct. 3, 2014 - Seeking Alpha
Biotech Stocks Rebound On Strong Earnings, New Drugs 5:32 p.m. Sept. 29, 2014 - Investors Business Daily
Can the Uptrend Continue for United Therapeutics (UTHR)? - Tale of the Tape 10:34 a.m. Sept. 24, 2014 - Zacks.com
Moving Average Crossover Alert: United Therapeutics (UTHR) - Tale of the Tape 9:09 a.m. Sept. 23, 2014 - Zacks.com
United Therapeutics Points To Pluristem's PLX-PAD As Its Most Transformative Product 9:49 a.m. Sept. 19, 2014 - Seeking Alpha
Press Releases on UTHR
Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors 6:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert 5:15 a.m. Oct. 31, 2014 - Marketwired
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 7:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
United Therapeutics Corporation Reports Third Quarter 2014 Financial Results 5:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014 5:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Creator of GeoStar and Sirius Radio, Martine Rothblatt to speak at the Church of Perpetual Life 3:06 p.m. Oct. 20, 2014 - PR Newswire - PRF
Upcoming Events, New Facilities, Technical Updates, and Pilot Programs - Research Reports on Aetna, United Therapeutics, Quest Diagnostics, Cummins and Danaher 7:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 8:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Axsome Therapeutics Announces Appointments to Its Board of Directors 6:31 a.m. Sept. 17, 2014 - GlobeNewswire
United Therapeutics Points to Pluristem's PLX-PAD as its Most Transformative Product 5:50 a.m. Sept. 17, 2014 - ACCESSWIRE
Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market 2:01 a.m. Sept. 16, 2014 - GlobeNewswire
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale 8:10 a.m. Sept. 12, 2014 - PR Newswire - PRF
United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension 2:01 a.m. Sept. 8, 2014 - GlobeNewswire
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 8:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver 8:31 a.m. Sept. 2, 2014 - PR Newswire - PRF
District Court Decision Received In Remodulin Patent Case 11:49 a.m. Aug. 29, 2014 - PR Newswire - PRF
Spinal Stenosis Global Clinical Trials Review, H2, 2014 6:20 p.m. Aug. 11, 2014 - PR Newswire - PRF
United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5:00 a.m. July 29, 2014 - PR Newswire - PRF
United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014 5:00 a.m. July 22, 2014 - PR Newswire - PRF
MarketWatch News on UTHR
Despite bullish backdrop, technical tests are in play 11:26 a.m. Sept. 9, 2014 - Michael Ashbaugh
Despite bullish backdrop, technical tests are in play 11:07 a.m. Sept. 9, 2014 - Michael Ashbaugh
Charting the technical (and bullish) cross currents 12:51 p.m. Feb. 21, 2014 - Michael Ashbaugh
CalAmp drops, ImmunoCellular rises after hours 6:07 p.m. Dec. 23, 2013 - Wallace Witkowski
Sell in November? No 10:52 a.m. Oct. 31, 2013 - Michael Ashbaugh
Charting the Nasdaq’s 12-year breakout 11:56 a.m. April 30, 2013 - Michael Ashbaugh
Charting the Nasdaq’s 12-year breakout 11:34 a.m. April 30, 2013 - Michael Ashbaugh
United Therapeutics: FDA again rejects drug 6:56 a.m. March 25, 2013 - MarketWatch.com
Look for bargains in health care, tech, energy, housing and airlines: Sabrient's Brown 4:46 p.m. Nov. 21, 2012 - blogs.marketwatch.com
Wednesday’s biggest movers: Facebook, Yelp rally 6:29 p.m. Oct. 24, 2012 - Sue Chang
FDA declines to OK United Therapeutics product 6:53 a.m. Oct. 24, 2012 - MarketWatch.com
Charting the longer-term market backdrop 11:30 a.m. Sept. 25, 2012 - Michael Ashbaugh
Charting the longer-term market backdrop 10:53 a.m. Sept. 25, 2012 - Michael Ashbaugh
S&P, Nasdaq retest major support 10:09 a.m. July 11, 2012 - Michael Ashbaugh
6 charts for the week 12:54 p.m. June 25, 2012 - The Trading Deck
13 stocks for 2012 5:57 p.m. Jan. 5, 2012 - blogs.marketwatch.com
Wednesday’s biggest gaining and declining stocks 3:29 p.m. Aug. 24, 2011 - Kate Gibson
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:50 p.m. June 6, 2011 - Kate Gibson
Utd Therapeutics hypertension drug hits trial goal 11:32 a.m. June 6, 2011 - MarketWatch.com
Other News on UTHR
The 3 Best ETFs for Mid-Cap Growth 5:50 a.m. Nov. 17, 2014 - InvestorPlace.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog 12:02 p.m. Oct. 29, 2014 - Zacks.com
United Therapeutics' (UTHR) CEO Martine Rothblatt on Q3 2014 Results - Earnings Call Transcript 6:10 p.m. Oct. 28, 2014 - Seeking Alpha
United Therapeutics ups revenues 9% in Q3 10:53 a.m. Oct. 28, 2014 - Seeking Alpha
Worst Performing Industries For October 28, 2014 10:13 a.m. Oct. 28, 2014 - benzinga.com
Weak On High Volume: United Therapeutics (UTHR) 10:04 a.m. Oct. 28, 2014 - TheStreet.com
United Therapeutics (UTHR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Oct. 28, 2014 - Seeking Alpha
10-Q: UNITED THERAPEUTICS CORP 6:06 a.m. Oct. 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
United Therapeutics Corporation (UTHR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 27, 2014 - Zacks.com
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 8:21 a.m. Oct. 24, 2014 - Seeking Alpha
Biotechs Show Fed Chief's Not Much Of A Stock Analyst 4:01 p.m. Oct. 22, 2014 - Investors Business Daily
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog 5:30 p.m. Oct. 14, 2014 - Zacks.com
J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog 11:27 a.m. Oct. 14, 2014 - Zacks.com
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. 10:58 a.m. Oct. 12, 2014 - GuruFocus.com
A Look At Arena's Other Drug 4:37 p.m. Oct. 3, 2014 - Seeking Alpha
Biotech Stocks Rebound On Strong Earnings, New Drugs 5:32 p.m. Sept. 29, 2014 - Investors Business Daily
Can the Uptrend Continue for United Therapeutics (UTHR)? - Tale of the Tape 10:34 a.m. Sept. 24, 2014 - Zacks.com
Moving Average Crossover Alert: United Therapeutics (UTHR) - Tale of the Tape 9:09 a.m. Sept. 23, 2014 - Zacks.com
United Therapeutics Points To Pluristem's PLX-PAD As Its Most Transformative Product 9:49 a.m. Sept. 19, 2014 - Seeking Alpha
Press Releases on UTHR
Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors 6:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert 5:15 a.m. Oct. 31, 2014 - Marketwired
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 7:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
United Therapeutics Corporation Reports Third Quarter 2014 Financial Results 5:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014 5:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Creator of GeoStar and Sirius Radio, Martine Rothblatt to speak at the Church of Perpetual Life 3:06 p.m. Oct. 20, 2014 - PR Newswire - PRF
Upcoming Events, New Facilities, Technical Updates, and Pilot Programs - Research Reports on Aetna, United Therapeutics, Quest Diagnostics, Cummins and Danaher 7:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 8:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Axsome Therapeutics Announces Appointments to Its Board of Directors 6:31 a.m. Sept. 17, 2014 - GlobeNewswire
United Therapeutics Points to Pluristem's PLX-PAD as its Most Transformative Product 5:50 a.m. Sept. 17, 2014 - ACCESSWIRE
Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market 2:01 a.m. Sept. 16, 2014 - GlobeNewswire
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale 8:10 a.m. Sept. 12, 2014 - PR Newswire - PRF
United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension 2:01 a.m. Sept. 8, 2014 - GlobeNewswire
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 8:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver 8:31 a.m. Sept. 2, 2014 - PR Newswire - PRF
District Court Decision Received In Remodulin Patent Case 11:49 a.m. Aug. 29, 2014 - PR Newswire - PRF
Spinal Stenosis Global Clinical Trials Review, H2, 2014 6:20 p.m. Aug. 11, 2014 - PR Newswire - PRF
United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5:00 a.m. July 29, 2014 - PR Newswire - PRF
United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014 5:00 a.m. July 22, 2014 - PR Newswire - PRF
(0)
(0)